- 1
- 2
Lysoway Therapeutics
Lysoway Therapeutics is an emerging biopharmaceutical company focusing on restoring or enhancing autophagy and lysosomal functions to treat a broad class of diseases.
Dr. Yongchang Qiu
Founder and Chief Executive OfficerMedical/Legal Genetics inc
A CAP, CLIA And AABB certified clinical lab specialized in genetic and molecular diagnosis
Dr. Helen Hua
MD, MS, MT(ASCP)Satyarx Pharma Innovations Private Limited
Satya is an early-stage Oncology biotech focused on discovering small molecule NCEs, with novel targets against well-established Oncogenes, Tumor suppressors and Synthetic Lethal targets. Satya's team has over 50 years' combined discovery expertise, having worked on over 75 targets and delivered 15 clinical candidates